TG Therapeutics Inc ASH Abstract Release Conference Call Transcript
Greetings, and welcome to TG Therapeutics Webinar ASH 2020 Abstract Release Call. (Operator Instructions). As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Michael Weiss, Chief Executive Officer of TG Therapeutics. Please proceed.
Great. Thank you, conference operator, and good morning, everybody, and thanks for joining us. So like a regular presentation, I guess, I'm going to do some forward-looking statements. Before I get started, I just want to remind everyone that I will be making some forward-looking statements. And for those who are interested in TG, I do encourage you to read our public disclosure documents available on the -- online.
Okay. So with that, let me start the call by just going through quickly the agenda for today. So first, I'm going to do a corporate update. The -- this will be in lieu of a quarterly conference call that we would normally host next week. So we're going to do some corporate housecleaning, do the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |